Account

Background Heartbeat

CBN South Africa: What the Sleep Evidence Actually Shows

Man sitting awake at 4:40am with insomnia, the sleep problem behind most CBN South Africa searches

CBN South Africa searches almost always come down to one question: does cannabinol actually help you sleep? The honest answer is that the human evidence is thin. A 2021 narrative review screened 99 human studies and found the clinical research on CBN dated and limited, most of it conducted in the 1970s. Animal work is more encouraging, and a randomised trial in insomnia disorder has been designed to test it properly. Legally, the low-dose exemptions South Africa granted for CBD were written for cannabidiol and do not extend to cannabinol.

Last updated:

Key takeaways

  • CBN, or cannabinol, is mostly a degradation product. It forms as THC oxidises with age, light and heat, which is why old cannabis contains more of it.
  • The “CBN makes you sleepy” claim is far more marketed than proven. The 2021 review that examined it directly concluded the clinical evidence does not support the claim as it is usually made.
  • A 2025 rat study using polysomnography did find CBN increased total sleep time, with a biphasic pattern, but animal sleep data does not transfer automatically to people.
  • The CBD carve-outs in SAHPRA’s 2020 scheduling notice name cannabidiol. Do not assume a CBN product sits outside the prescription framework because a CBD product might.
  • Products sold as CBN isolate are frequently mislabelled internationally. Ask for a batch certificate of analysis before you spend money.

What CBN is, and why it turns up in cannabis products

Cannabinol is one of the minor cannabinoids. Unlike THC and CBD, which the plant produces in quantity, CBN is largely something that happens to cannabis rather than something cannabis makes. THC oxidises over time, and CBN is the main product of that reaction. Heat, light and air all accelerate it.

Most CBN South Africa product listings lead with the sleep claim and say very little about where the compound comes from, which is where the confusion starts.

That single fact explains most of the folklore. Old, badly stored cannabis has more CBN in it and is often described as more sedating. The intuitive conclusion, that CBN is the sedating part, is exactly the kind of inference that feels obvious and turns out to be unsupported when somebody tests it.

Pharmacologically, CBN is a weak partial agonist at the CB1 receptor, the receptor THC acts on. That gives it a plausible mechanism for mild psychoactive and sedative effects, but plausible mechanism and demonstrated clinical effect are different claims, and the gap between them is where most cannabinoid marketing lives.

Does CBN actually help you sleep? What the evidence shows

This deserves a straight answer, because it is the reason almost anyone looks CBN up.

The most direct assessment is a 2021 narrative review in Cannabis and Cannabinoid Research titled, pointedly, “Cannabinol and Sleep: Separating Fact from Fiction”. The author ran a systematic PubMed search, screened the abstracts of 99 human studies, and found eight full-text articles meeting the inclusion criteria. The finding was that pre-clinical and clinical research on CBN is dated and limited, with most human studies dating from the 1970s. The review did not find sufficient clinical evidence to support the sleep-promoting claims being made for CBN products.

The picture in animals is more interesting. A 2025 study in Neuropsychopharmacology used polysomnography, an objective sleep measure, to test CBN in rats. CBN increased total sleep time and increased both non-REM and REM sleep. The effect was biphasic: sleep was initially suppressed before it increased substantially. That is a genuine signal and it is the first objective sleep-architecture data for the compound. It is also a rat study, and rats are not a reliable guide to how a compound will perform in humans with insomnia disorder.

The gap is being addressed. The CUPID study, whose protocol was published in BMJ Open in 2023, is a randomised trial testing CBN at 30 mg and 300 mg against placebo for sleep and next-day function in people with insomnia disorder. That is the right way to answer the question. Until trials like it report, anyone telling you CBN is a proven sleep aid is ahead of the evidence.

Unbranded amber cannabinoid oil dropper bottles, the kind of label a buyer needs to read carefully

Before you start

In South Africa, medical cannabis containing THC is prescription-only through a registered doctor, usually via a SAHPRA Section 21 authorisation. This is general information for adults 18 and over, not medical advice. Persistent insomnia has causes worth investigating, including sleep apnoea, depression and thyroid disease, and it responds well to cognitive behavioural therapy for insomnia. Speak to a doctor or pharmacist before starting, stopping or changing any treatment, especially about dosing.

Where CBN South Africa sits legally

Start with the general rule. Section 22A(16)(b) of the Medicines and Related Substances Act 101 of 1965 provides that a person may possess a Schedule 3, 4, 5 or 6 substance only if they hold a prescription issued by an authorised prescriber. Anything inside the scheduled framework needs a prescription. That is the baseline every cannabinoid question resolves against.

Next, the cannabis-specific scheduling. SAHPRA’s communication to industry on the scheduling status of THC and CBD, published as GN 586 in Government Gazette 43347 on 22 May 2020, is the notice everyone cites. It places THC in Schedule 6 with narrow exceptions, and CBD in Schedule 4 with defined low-dose exemptions that drop certain complementary products to Schedule 0.

Read the title of that notice carefully, because it is the point most CBN sellers gloss over. The notice addresses THC and cannabidiol. The low-dose exemption is written for cannabidiol as a named substance. It is not a general “minor cannabinoids are fine” provision, and nothing in it says cannabinol inherits the carve-out. Anyone marketing a CBN product on the basis that “CBD is legal at low doses” is reasoning by analogy from a notice that does not name their compound.

Two further points matter for anyone weighing CBN South Africa claims. First, CBN products are typically made from cannabis, and a cannabis extract is a cannabis product regardless of which cannabinoid the label leads with. Second, most cannabis medicines available here are not registered with SAHPRA, so lawful medical access generally runs through a Section 21 authorisation applied for by your prescriber. Our step-by-step guide to the Section 21 process explains who does what.

The Cannabis for Private Purposes Act 7 of 2024 changed the position on private adult use and cultivation. It did not create a commercial retail route for cannabinoid products, and it does not turn a CBN sleep product into an unscheduled consumer good.

If you want a definitive answer for one specific product, the questions to put to the seller are which schedule the product falls under and on what basis, and to your prescriber or pharmacist whether it can be supplied to you lawfully. A confident verbal assurance from a retailer is not a scheduling determination.

CBN compared with CBD and THC

 CBN (cannabinol)CBD (cannabidiol)THC
OriginMostly formed as THC degrades with age, heat and lightProduced by the plant in quantityProduced by the plant in quantity
IntoxicatingWeakly, as a partial CB1 agonistNoYes
Human evidence baseThin and dated; trials in progressSubstantial, including a registered epilepsy medicineSubstantial, strongest for specific indications
Named in the 2020 SA scheduling noticeNoYes, Schedule 4 with low-dose exemptionsYes, Schedule 6 with narrow exceptions

The practical reading of that table is not that CBN is dangerous. It is that CBN currently has the weakest evidence base and the least regulatory clarity of the three, which is an unusual combination to find in a product marketed as a gentle everyday sleep aid.

What to check before buying any CBN product

If you decide to pursue a CBN South Africa product anyway, these are the checks that separate a serious product from a label.

  • A batch certificate of analysis. Not a generic company document, a certificate tied to the batch number on your bottle, from an independent laboratory, showing the actual cannabinoid content.
  • The THC figure. Because CBN comes from THC, CBN-rich extracts frequently carry residual THC. That is the number determining which schedule you are dealing with.
  • Whether the stated CBN content is plausible. Online cannabinoid labelling has a documented accuracy problem. A 2017 JAMA analysis of cannabidiol extracts sold online found that most were inaccurately labelled against laboratory analysis. That study looked at CBD rather than CBN, and CBN is the smaller and less scrutinised market of the two. Treat an unverified number as marketing until a laboratory confirms it.
  • Who is selling it, and under what authorisation. A retailer who cannot say which schedule the product falls under has not done the work.
  • Your other medicines. Cannabinoids interact with several liver enzymes that also process prescription drugs. Our guide to cannabis drug interactions covers the groups that matter most.

And a point worth stating plainly: if the sleep problem has lasted more than a few weeks, the highest-value step is not a cannabinoid at all. It is having the insomnia properly assessed. Sleep apnoea, depression, thyroid disease and medication side effects all present as insomnia, and cognitive behavioural therapy for insomnia has a stronger evidence base than any cannabinoid currently does.

How Professor Green fits into the process

Professor Green is a South African medical cannabis platform. Registering creates your account and starts the legal access process by connecting you to the registered prescriber route.

To be exact about the limits: Professor Green does not diagnose, does not prescribe, does not submit Section 21 applications and does not dispense. Those acts belong to a registered medical practitioner and a licensed pharmacy. Professor Green also does not determine the scheduling status of any product, and nothing here should be read as advice that a particular CBN product is lawful for you to possess.

What the platform offers is a defined starting point for people who want the supervised route: an account, and entry to a process where a prescriber assesses you and any medicine is dispensed against a valid prescription. It is not a guarantee of eligibility, approval or supply of any particular product, and it is not a shortcut around the evidence problem described above. If cannabinoids turn out to be right for your situation, that is a decision for a prescriber who has seen your history.

If, having read the evidence honestly, you want to explore the legal medical route rather than an unverified retail product, you can register for store access. If you would rather read more first, our overview of what the evidence shows for medical cannabis in chronic pain takes the same approach to a better-studied question, and our guide to monitoring after starting treatment covers what happens next.

The honest summary

CBN is a real compound with a plausible mechanism, one good animal study on sleep architecture, a review that found the human evidence wanting, and a properly designed trial still working through the question. That is an interesting research position. It is not a finished answer, and it does not justify the confidence with which CBN is currently sold.

For anyone weighing CBN South Africa claims today, the sensible position is scepticism about the marketing, interest in the science, and clarity about the law: the CBD low-dose exemption names cannabidiol, and a prescription requirement applies to anything inside the scheduled framework. If sleep is the actual problem, get the insomnia assessed first.

Frequently asked questions about CBN in South Africa

Is CBN legal in South Africa?
There is no separate carve-out for cannabinol. SAHPRA’s 2020 scheduling notice (GN 586, Government Gazette 43347) addresses THC and cannabidiol, and the low-dose exemption is written for cannabidiol. Anything within the scheduled framework requires a prescription from an authorised prescriber under section 22A(16)(b) of the Medicines Act. Ask the seller which schedule their specific product falls under and on what basis.

Does CBN actually make you sleepy?
The evidence is weaker than the marketing. A 2021 narrative review in Cannabis and Cannabinoid Research screened 99 human studies and concluded the clinical research was dated and limited, mostly from the 1970s, and did not support the sleep-promoting claims. A 2025 rat study using polysomnography did find increased total sleep time, and a randomised human trial in insomnia disorder has been designed to settle the question.

Why does old cannabis contain more CBN?
CBN is mainly a degradation product. THC oxidises over time, and heat, light and air speed the reaction up, so poorly stored or aged cannabis contains proportionally more cannabinol.

Is CBN the same as CBD?
No. CBD is produced by the plant in quantity and is not intoxicating. CBN forms mostly as THC degrades and is a weak partial agonist at the CB1 receptor, so it has mild intoxicating potential. They also sit differently in South African scheduling.

Will a CBN product show up on a drug test?
It can. CBN-rich extracts are made from cannabis and frequently carry residual THC, which is what most workplace tests look for. If testing matters to you, insist on a batch certificate of analysis showing the THC content.

Can I get CBN on prescription in South Africa?
Any decision about a cannabinoid medicine is for a registered prescriber who has assessed you. Because most cannabis medicines here are unregistered, access generally runs through a SAHPRA Section 21 authorisation that the prescriber applies for.

Are CBN products accurately labelled?
Cannabinoid labelling has a documented accuracy problem. A 2017 JAMA analysis of cannabidiol extracts sold online found most were inaccurately labelled against laboratory testing, and CBN is a smaller, less scrutinised market than CBD. Ask for a batch-specific certificate of analysis from an independent laboratory.

What should I do about insomnia while the CBN evidence catches up?
Have persistent insomnia assessed. Sleep apnoea, depression, thyroid disease and medication side effects all present as insomnia, and cognitive behavioural therapy for insomnia has a stronger evidence base than any cannabinoid currently does.

Sources and references

Prefer the supervised route to an unverified label

If reading the CBN South Africa evidence has convinced you to go through a prescriber rather than an online seller, the next step is to create your account. Professor Green connects you with the registered prescriber route. Registration is the first step and is not a guarantee of eligibility, approval or supply.

Register for legal access
Share the Post:

Related Posts

Professorgreen.co.za is ran by Green Tec LLC is an authorised marketing affiliate for the Dr Green network who holds the Medical Cannabis licences in South Africa. We do not sell, handle, or ship cannabis. All cannabis products are sold and fulfilled by licensed operator DR Green.

Our Social